Factors that propel the Global Autoimmune Disease Diagnostics Market are rising cases of
autoimmune diseases and surging healthcare expenditure. Encouraging
governmental policies regarding autoimmune diagnostics & research has a
positive impact on market demand. Autoimmune diseases are a key cause of women
deaths worldwide. Furthermore, active awareness initiatives regarding diagnosis
of diseases may contribute significantly to the global industry during the
forecast period (2012 to 2020). A large number of laboratories have begun
installing equipment that can carry out several tests simultaneously and
deliver quick results. Automation in laboratory procedures ensures greater
efficiency.
The worldwide autoimmune disease diagnostics
market is categorized on the basis of products and regions. On the basis of
products, there are two key segments, namely, localized disease diagnostics and
systemic autoimmune disease diagnostics. Owing to greater patient awareness and
huge procedure volumes, the localized disease diagnostics segment held the
highest share in 2013.
Browse Details of Report@
A number of unmet medical needs in type 1
diabetics is a key factor that drives this segment. The systemic autoimmune
disease diagnostics segment mainly involves the diagnosis of diseases, such as
rheumatoid arthritis, lupus erythematosus (SLE), and Ankylosing spondylitis.
The rheumatoid arthritis segment holds the highest share in the industry
because it is the most frequently occurring inflammatory ailment worldwide. It
is led by product innovation.
On the basis of geographies, the global
autoimmune disease diagnostics market is divided into Europe, Asia Pacific,
North America, and Rest of the World. In revenue terms, North America was the
largest market in 2013. This region is propelled by a well developed healthcare
infrastructure and positive government initiatives, such as the Affordable Care
Act and Patient Protection Act.
In terms of yearly expenditure on autoimmune
disease diagnostics, North America ranks number one in the overall industry.
Moreover, surging per capita spending on healthcare is projected to
significantly drive regional growth till 2020. Europe, the second largest
market after North America, is propelled by technological advancements and high
cases of autoimmune diseases. These technological developments are mainly
observed in portable diagnostics equipment and biomarkers. Europe may derive
much of its demand for autoimmune disease diagnostics from Eastern Europe.
Being a highly consolidated one, the global
market for autoimmune disease diagnostics market witnesses frequent mergers
& acquisitions. It is a moderately competitive industry that is led by
innovations and price wars. Key competitors in the global industry are Bio Rad,
Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, and Abbott
Diagnostics.
In October 2016, IQuity, a diagnostics
technology company launched the IQIsolate® technology. This technology helps
identify autoimmune anomalies during its early stages. It analyzes the RNA
structures in blood samples. Interestingly, IQIsolate® has exhibited ninety
percent accuracy in three key medical specialties, namely, rheumatology,
gastroenterology, and neurology. The company asserts that its technology can
significantly reduce the diagnostics processes of complex autoimmune diseases.
It can also differentiate between diseases that show similar symptoms. A
striking feature of IQuity’s blood based diagnostic technology is that it helps
providers & physicians confirm other types of autoimmune anomalies within a
week. It is expected to gradually commercialize newer test panels that focus on
rheumatology and gastroenterology.
Browse Related Category Market Reports @
About Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Website - http://www.hexaresearch.com/
Visit Our Blog - hexaresearch1.blogspot.com
No comments:
Post a Comment